Amani Therapeutics
Biotechnology company developing combination medicines for serious neuropsychiatric disorders.
$25MSeries A
Role not disclosedRI
RTW Investments
Activity from announced rounds
Activity in this selectionHealthtech
RTW Investments is the investment manager named in Amani and Encoded financing histories.
Recorded funding activity
Amani develops combination medicines for neuropsychiatric disorders. Encoded develops gene-regulation therapies for neurological disease. The histories refer to the manager rather than a specified RTW fund.
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $25M 1 disclosed · full round size, not this investor’s share